Design and synthesis of novel isoquinoline-3-nitriles as orally bioavailable Kv1.5 antagonists for the treatment of atrial fibrillation.

Source:http://linkedlifedata.com/resource/pubmed/id/17125248

J. Med. Chem. 2006 Nov 30 49 24 6954-7

Download in:

View as

General Info

PMID
17125248